Webcast with CEOs of Swedish Alzheimer’s companies

Date: 2021-03-19

Our CEO, Kristina Torfgård, recently participated in a webcast discussion on Alzheimer's disease together with the CEOs of two other Swedish companies developing therapies to improve the lives of Alzheimer patients.

The discussion, which was presented and hosted by Redeye, revolved around latest Alzheimer’s research updates, disease targets and company news flows, including Alzinova’s upcoming clinical study with its therapeutic vaccine, ALZ-101.

Click the link to see a recording of the panel discussion (in Swedish).